CDSCO tightens oversight on semaglutide after Interpol flags counterfeit batch

India warns against unverified semaglutide imports

With more people in India turning to semaglutide (especially since generics launched after its patent expired in March), the market is booming, but so are risks of fakes.
Regulators are now cracking down on supply chains, urging only medical use under supervision, and warning against buying unverified imports to keep patients safe.